Filtered By:
Management: Government
This page shows you your search results in order of date. This is page number 17.
Order by Relevance | Date
Total 334 results found since Jan 2013.
Mylan CEO Testifies on EpiPen Cost
WASHINGTON (AP) — Mylan CEO Heather Bresch infuriated lawmakers as she tried — and mostly failed — to explain steep cost increases of her company's life-saving EpiPens.
Outraged Republican and Democratic lawmakers on Wednesday grilled Bresch about the emergency allergy shot's sky-high price and the profits for a company with sales in excess of $11 billion. The list price of EpiPens has grown to $608 for a two-pack, an increase of more than 500 percent since 2007.
In almost four hours of questioning, the soft-spoken CEO at times seemed unsure, or declined to answer directly, when asked questions about the compan...
Source: JEMS: Journal of Emergency Medical Services News - September 23, 2016 Category: Emergency Medicine Tags: News Patient Care Source Type: news
PITTSBURGH: Mylan CEO plans to defend EpiPen price
PITTSBURGH — The Senate Banking Committee had its turn with Wells Fargo CEO John Stumpf on Tuesday. Today, the spotlight shifts to Mylan CEO Heather Bresch, who goes before the House Oversight and Government Reform Committee to testify about pricing for her company’s EpiPen, the emergency allergy shot that has seen its price increase more than 500 percent since 2007.
In testimony released last night, Bresch said, “Price and access exist in a balance, and we believe we have struck that balance,”…
Source: bizjournals.com Health Care:Biotechnology headlines - September 21, 2016 Category: Biotechnology Authors: David A. Arnott Source Type: news
Senate Republicans seek probe of Mylan EpiPen oversight
NEW YORK (Reuters) - Mylan NV faced new scrutiny over price hikes for its anti-allergy EpiPen on Tuesday, with U.S. lawmakers calling for a probe of oversight of the company ’s rebates to government healthcare plans, while West Virginia said it was investigating whether Mylan defrauded its Medicaid department.
Source: Reuters: Health - September 21, 2016 Category: Consumer Health News Tags: healthNews Source Type: news
U.S. Senate committee chair: Mylan's response on EpiPen price hike 'incomplete'
WASHINGTON (Reuters) - The chairman of the U.S. Senate Judiciary Committee probing Mylan NV's EpiPen price hike on Friday said its response to his query was "incomplete," and called on the drugmaker to give more details over how much government health insurance programs pay for the allergy treatment.
Source: Reuters: Health - September 9, 2016 Category: Consumer Health News Tags: healthNews Source Type: news
U.S. lawmakers question Mylan's Medicaid EpiPen rebates
(Reuters) - Two key U.S. congressional committee members on Friday called for an investigation into whether Mylan NV, under fire for raising the price of its EpiPen device, overcharged the government's low-income healthcare program for the allergy treatment.
Source: Reuters: Health - September 2, 2016 Category: Consumer Health News Tags: healthNews Source Type: news
Multifocal effort needed to rein in prescription prices
Enforcing more stringent requirements for exclusivity rights, ensuring timely generic drug availability, and providing greater opportunities for meaningful price negotiation by government payers could help combat high medication costs in the United States, according to an analysis published Aug. 23...
Source: Skin and Allergy News - August 23, 2016 Category: Dermatology Source Type: news
More Kids Will Get Vaccinated Under New California Law
This piece comes to us courtesy of EdSource, where it was originally published.
Mississippi hasn’t had a case of measles since 1992. West Virginia last saw measles – a highly contagious virus that kills an estimated 314 people worldwide every day – in 2009. Now, with California’s new vaccination law rolling out shot by shot, the state joins Mississippi and West Virginia to become the third in the nation to adopt stringent vaccination school entrance requirements. And medical experts say disease rates are likely to fall in California as they have in those states.
“It’s a good club to...
Source: Healthy Living - The Huffington Post - August 15, 2016 Category: Consumer Health News Source Type: news
FBI questions legality of telemedicine compact laws
The FBI is raising concerns that language in the Interstate Medical Licensure Compact violates federal regulations over criminal background checks. The government pushback could mean implementation delays of telemedicine legislation that 17 states have <a...
Source: Skin and Allergy News - August 15, 2016 Category: Dermatology Source Type: news
Mobile health applications in clinical practice: pearls, pitfalls, and key considerations
This article aims to inform physicians on the background of mobile health applications, including key definitions, how mobile health applications are currently used by patients and health care professionals, and the potential benefits of this technology in improving patient outcomes.
Source: Annals of Allergy, Asthma and Immunology - July 31, 2016 Category: Allergy & Immunology Authors: Victoria E. Cook, Anne K. Ellis, Kyla J. Hildebrand Tags: CME Review Source Type: research
"It's A Scandal" -Daryl Hall on Doctors Denying Chronic Lyme
Growing up a musically-obsessed child in the 80's, Daryl Hall was one of my biggest inspirations. A masterful, inventive songwriter with an ocean of soul, he set me on the path to being an artist, to never waste a word, and to sing because I mean it.
With six number ones and five additional top ten hits throughout the 70's and 80's Daryl Hall and John Oates are the number one duo in music history. Still at the top of his game at 69 years old, Daryl has won legions of new fans with his hit MTV Live show Live From Daryl's House.
In February of 2015, at my very sickest from chronic Lyme and Bartonella, after it was missed b...
Source: Science - The Huffington Post - July 22, 2016 Category: Science Source Type: news
Supreme Court offers mixed take on false claim liability
A U.S. Supreme Court ruling that expands liability under the federal False Claims Act (FCA) could have both positive and negative implications for physicians accused of submitting false claims to the government.
Justices <a...
Source: Skin and Allergy News - July 19, 2016 Category: Dermatology Source Type: news
Understanding the Pathophysiology and Challenges of Development of Medical Countermeasures for Radiation-Induced Vascular/Endothelial Cell Injuries: Report of a NIAID Workshop, August 20, 2015.
This article provides a summary of these presentations and subsequent discussion from the workshop.
PMID: 27387859 [PubMed - as supplied by publisher]
Source: Radiation Research - July 6, 2016 Category: Physics Authors: Satyamitra MM, DiCarlo AL, Taliaferro L Tags: Radiat Res Source Type: research
301 People Charged With $900 Million in False Medicare Billings
(MedPage Today) -- Largest sweep since government fraud team began in 2007
Source: MedPage Today Allergy - June 22, 2016 Category: Allergy & Immunology Source Type: news
Summary and recommendations from a National Institute of Allergy and Infectious Diseases (NIAID) workshop on "Gonorrhea Vaccines: the Way Forward".
Abstract
There is an urgent need for the development of an anti-gonococcal vaccine due to the increasing drug resistance found in this pathogen. The U.S. Center for Disease Control (CDC) has identified multidrug-resistant gonococci (GC) as one of 3 "urgent" hazard level threats to the U.S.
POPULATION: In light of this, on June 29-30, 2015, the National Institute for Allergy and Infectious Diseases (NIAID) sponsored a workshop entitled "Gonorrhea Vaccines: the Way Forward". The goals of the workshop were to gather leaders in the field to discuss several key questions on the current status of gonorrhea vaccine ...
Source: Clinical and Vaccine Immunology - June 21, 2016 Category: Allergy & Immunology Authors: Wetzler LM, Feavers IM, Gray-Owen SD, Jerse AE, Rice PA, Deal CD Tags: Clin Vaccine Immunol Source Type: research
Judge says feds overstepped on ACA cost-sharing subsidies
The Obama administration suffered another legal judgment against the Affordable Care Act when a district court judge ruled that the government has wrongly spent billions of dollars to repay insurers for health insurance provided to certain low-income patients
Congress never appropriated the money...
Source: Skin and Allergy News - May 23, 2016 Category: Dermatology Source Type: news
